• Home
  • /
  • Posts
  • /
  • Aurora Cannabis (TSX:ACB) Posts Poor Final Quarter Results

September 11, 2019

Aurora Cannabis (TSX:ACB) Posts Poor Final Quarter Results

By Dan Kent

September 11, 2019

The Cannabis industry has been in turmoil over the last 6 months. Popular Canadian marijuana ETF HMMJ has fallen over 42% since October 2018 highs and there doesn’t seem to be an end in sight.

Cannabis investors worldwide were anticipating Aurora Cannabis’s (TSX:ACB) fourth quarter results, and the Canadian cannabis company missed the mark by a large margin.

One of the major disappointments on the year was the company’s EBITDA. Aurora had confirmed not long ago that it was on its way to achieving positive EBITDA for the quarter. Guidance was missed extensively, as the company filed a EBITDA loss of nearly $12 million.

Key highlights from Aurora’s fourth quarter

In terms of revenue, it was a strong fourth quarter and fiscal 2019 overall for the company. Aurora has more than doubled its cash on hand and has saw an increase in revenue year over year of 349%. Gross profits came in at $159.8 million, 267% higher than 2018.

Consumer cannabis sales were up 52% compared to Q3 and production volume nearly doubled at just over 29,000 kgs. The company is seeing its margins increase as its cash cost to produce per gram fell 20% when compared to the third quarter.

Average selling price has fallen

Aurora is producing more cannabis, but unfortunately the net selling price for its product is falling. Medical cannabis maintained its selling price at $8.51 and their bulk sales were up 3% at $3.61.

The biggest revenue driver for the company though, its consumer cannabis market, saw net selling price fall from $5.48 in the third quarter to $5.14 to end the year, a decrease of 6%.

With kilograms sold making up only 61% of kilograms produced, it is clear there is an oversupply issue, which has burdened the industry for some time now.

Earnings and revenue both miss analyst expectations

Analysts expected Aurora to post a loss of around $0.05 on the quarter and revenues in the $108.3 million mark. Unfortunately, the company missed on both by a decent sized margin.

With a loss of $0.29 per share, it was a near 600% miss for the company to finish off 2019. Net revenue of $98.9 million missed the mark by almost 10%.

This isn’t the first time a Canadian cannabis company has come up well short of analyst expectations. Canopy Growth missed by a significant margin in its latest quarterly filing.

What does this mean for the industry moving forward?

With valuations as high as they are in the cannabis industry, it is going to need a company to step up to the plate and become a frontrunner. A company can grow its revenue at whatever increments it wants, but the end result of a strong company is profitability, not sales.

Sure, margins are increasing. But as we saw this quarter with Aurora, average cost per unit sold is also decreasing. Slowing growth is financial doom for stocks valued this high.

Edible legalization may provide tailwinds for the industry heading in to the end of 2018, but I wouldn’t bank on it. Investors were already fooled by legalization last October, so don’t trade these Canadian stocks expecting the same thing. They’ve been some of the biggest losers on the TSX in quite some time.

 

Related Posts

Canadian Healthcare Stocks For Outsized Returns

The Best Canadian Marijuana Stocks To Invest In Now

Cannabis Stocks Crumble, HEXO (TSE:HEXO) Drops Guidance

How Far Can Canopy Growth (TSE:WEED) Really Fall?

Dan Kent


An active dividend and growth investor, Dan has been involved with the website since its inception. Dan is primarily a researcher and writer here at Stocktrades.ca, and his pieces have numerous mentions on the Globe and Mail, Forbes, Winnipeg Free Press, and other high authority financial websites. He has become an authority figure in the Canadian finance niche, primarily due to his attention to detail and overall dedication to achieving the highest returns on his investments. Investing on his own since he was 19 years old, Dan has compiled the experience and knowledge needed to be successful in the world of self-directed investing, and is always happy to bring that knowledge to Stocktrades.ca readers and any other publications that give him the opportunity to write. Dan manages his TFSA, RRSPs and a LIRA at Questrade, and has compiled a real estate portfolio of his primary residence and 2 rental properties, all before his 30th birthday.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}